Cargando…

Natural Dietary Compound Xanthohumol Regulates the Gut Microbiota and Its Metabolic Profile in a Mouse Model of Alzheimer’s Disease

Discovering new and effective drugs for the treatment of Alzheimer’s disease (AD) is a major clinical challenge. This study focuses on chemical modulation of the gut microbiome in an established murine AD model. We used the 16S rDNA sequencing technique to investigate the effect of xanthohumol (Xn)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wei, He, Kaiwu, Wu, Desheng, Zhou, Li, Li, Guowei, Lin, Zequn, Yang, Xifei, Liu, Jianjun, Pui Man Hoi, Maggie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880053/ https://www.ncbi.nlm.nih.gov/pubmed/35209070 http://dx.doi.org/10.3390/molecules27041281

Ejemplares similares

Evaluation of therapeutic effects of tetramethylpyrazine nitrone in Alzheimer’s disease mouse model and proteomics analysis
por: Zhou, Xinhua, et al.
Publicado: (2023)

The Prenylflavonoid Xanthohumol Reduces Alzheimer-Like Changes and Modulates Multiple Pathogenic Molecular Pathways in the Neuro2a/APP(swe) Cell Model of AD
por: Huang, Xianfeng, et al.
Publicado: (2018)

Synthesis of xanthohumol and xanthohumol-d(3) from naringenin
por: Andrusiak, Joanna, et al.
Publicado: (2021)

Dietary compounds in modulation of gut microbiota-derived metabolites
por: Feng, Wuwen, et al.
Publicado: (2022)

Adiponectin alleviated Alzheimer‐like pathologies via autophagy‐lysosomal activation
por: He, Kaiwu, et al.
Publicado: (2021)

Memantine Improves Cognitive Function and Alters Hippocampal and Cortical Proteome in Triple Transgenic Mouse Model of Alzheimer's Disease
por: Zhou, Xinhua, et al.
Publicado: (2019)

Loganin substantially ameliorates molecular deficits, pathologies and cognitive impairment in a mouse model of Alzheimer’s disease
por: Nie, Lulin, et al.
Publicado: (2021)

Emerging roles of astrocytes in blood-brain barrier disruption upon amyloid-beta insults in Alzheimer’s disease
por: Yue, Qian, et al.
Publicado: (2023)

Movement deficits and neuronal loss in basal ganglia in TRPC1 deficient mice
por: He, Kaiwu, et al.
Publicado: (2016)

An extended reconstruction of human gut microbiota metabolism of dietary compounds
por: Blasco, Telmo, et al.
Publicado: (2021)

Dietary Phenolic Compounds: Their Health Benefits and Association with the Gut Microbiota
por: Matsumura, Yoko, et al.
Publicado: (2023)

Therapeutic efficacy of novel memantine nitrate MN‐08 in animal models of Alzheimer’s disease
por: Wu, Liangmiao, et al.
Publicado: (2021)

Pharmacological Profile of Xanthohumol, a Prenylated Flavonoid from Hops (Humulus lupulus)
por: Liu, Ming, et al.
Publicado: (2015)

Antiproliferative and apoptotic effects of xanthohumol in cholangiocarcinoma
por: Walden, Daniel, et al.
Publicado: (2017)

Microbial Conjugation Studies of Licochalcones and Xanthohumol
por: Han, Fubo, et al.
Publicado: (2021)

Dietary Exposure to the Environmental Chemical, PFOS on the Diversity of Gut Microbiota, Associated With the Development of Metabolic Syndrome
por: Lai, Keng Po, et al.
Publicado: (2018)

Gut Microbiota and its Metabolites: Bridge of Dietary Nutrients and Alzheimer’s Disease
por: Zhu, Guangsu, et al.
Publicado: (2023)

Novel anti-obesity effects of beer hops compound xanthohumol: role of AMPK signaling pathway
por: Samuels, Janaiya S., et al.
Publicado: (2018)

Gut Microbiota and Immunotherapy for Alzheimer’s Disease
por: Dai, Chun-Ling, et al.
Publicado: (2022)

Dietary Regulation of Gut-Brain Axis in Alzheimer’s Disease: Importance of Microbiota Metabolites
por: Frausto, Dulce M., et al.
Publicado: (2021)

Determination of the binding mode for anti-inflammatory natural product xanthohumol with myeloid differentiation protein 2
por: Fu, Weitao, et al.
Publicado: (2016)

Gut Microbiota: Implications in Alzheimer’s Disease
por: He, Yixi, et al.
Publicado: (2020)

Xanthohumol relieves arthritis pain in mice by suppressing mitochondrial-mediated inflammation
por: Wang, Qin, et al.
Publicado: (2023)

Xanthohumol attenuates renal ischemia/reperfusion injury by inhibiting ferroptosis
por: Tang, Zhe, et al.
Publicado: (2023)

Xanthohumol inhibits colorectal cancer cells via downregulation of Hexokinases II-mediated glycolysis
por: Liu, Wenbin, et al.
Publicado: (2019)

Xanthohumol suppresses glioblastoma via modulation of Hexokinase 2 -mediated glycolysis
por: Yuan, Jian, et al.
Publicado: (2020)

Low-Dose Copper Exposure Exacerbates Depression-Like Behavior in ApoE4 Transgenic Mice
por: Xu, Jia, et al.
Publicado: (2021)

Bioactivity, bioavailability, and gut microbiota transformations of dietary phenolic compounds: implications for COVID-19
por: Augusti, Paula R., et al.
Publicado: (2021)

Xanthohumol, a Prenylated Chalcone from Hops, Inhibits the Viability and Stemness of Doxorubicin-Resistant MCF-7/ADR Cells
por: Liu, Ming, et al.
Publicado: (2016)

Evidence for the Effects of Xanthohumol in Disrupting Angiogenic, but not Stable Vessels
por: Negrão, Rita, et al.
Publicado: (2007)

Antimicrobial Activity of Xanthohumol and Its Selected Structural Analogues
por: Stompor, Monika, et al.
Publicado: (2016)

Determination of Xanthohumol in Hops, Food Supplements and Beers by HPLC
por: Vázquez Loureiro, Patricia, et al.
Publicado: (2019)

Xanthohumol for Human Malignancies: Chemistry, Pharmacokinetics and Molecular Targets
por: Harish, Vancha, et al.
Publicado: (2021)

Xanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease
por: Lin, Yuxi, et al.
Publicado: (2021)

Effects of gut microbiota and probiotics on Alzheimer’s disease
por: Guo, Libing, et al.
Publicado: (2021)

Inhibition of Osteoclastogenesis and Bone Resorption in vitro and in vivo by a prenylflavonoid xanthohumol from hops
por: Li, Jing, et al.
Publicado: (2015)

Effects of dietary organic acids and nature identical compounds on growth, immune parameters and gut microbiota of European sea bass
por: Busti, Serena, et al.
Publicado: (2020)

The Characteristics, Mechanisms and Therapeutics: Exploring the Role of Gut Microbiota in Obesity
por: Zhuang, Zequn, et al.
Publicado: (2023)

Targeting Gut Microbiota for the Prevention and Management of Diabetes Mellitus by Dietary Natural Products
por: Li, Bang-Yan, et al.
Publicado: (2019)

The effects of traditional Chinese medicine and dietary compounds on digestive cancer immunotherapy and gut microbiota modulation: A review
por: Feng, Xiaoli, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_at0h0pt7q6bigua754q5c1pbog